Crossmark

Impact-Driven Strategies for Optimizing Inhaled Therapy Adherence in COPD: The OPTIMO Delphi Consensus

Crossref DOI link: https://doi.org/10.1016/j.opresp.2026.100587

Published Print: 2026-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Alcázar Navarrete, Bernardino

Alonso Ortiz, María Belén

Doña Díaz, Esperanza

Echave-Sustaeta María-Tomé, José María

Gargantilla Madera, Pedro

González Villaescusa, Cruz

Maya Viejo, José David

Navarro Ros, Fernando María

Trillo Calvo, Eva

Turegano-Yedro, Miguel

Martínez Ferreras, Alfonso
Funding

Funding for this research was provided by:

GlaxoSmithKline

GlaxoSmithKline España
License Information

Text and Data Mining valid from 2026-04-01

Text and Data Mining valid from 2026-04-01

Version of Record valid from 2026-01-29
More Information

This article is maintained by: Elsevier

Article Title: Impact-Driven Strategies for Optimizing Inhaled Therapy Adherence in COPD: The OPTIMO Delphi Consensus

Journal Title: Open Respiratory Archives

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.opresp.2026.100587

Content Type: article

Copyright: © 2026 Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Published by Elsevier España, S.L.U.